Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • StackAI Reviews & Ratings
    53 Ratings
    Company Website
  • SalesTarget.ai Reviews & Ratings
    30 Ratings
    Company Website
  • TextUs Reviews & Ratings
    857 Ratings
    Company Website
  • DbVisualizer Reviews & Ratings
    572 Ratings
    Company Website
  • Shape Software Reviews & Ratings
    134 Ratings
    Company Website
  • PathSolutions TotalView Reviews & Ratings
    43 Ratings
    Company Website
  • Revaly Reviews & Ratings
    7 Ratings
    Company Website
  • Healthee Reviews & Ratings
    13 Ratings
    Company Website
  • JetBrains Junie Reviews & Ratings
    12 Ratings
    Company Website
  • Paligo Reviews & Ratings
    99 Ratings
    Company Website

What is SpliceCore?

Utilizing RNA sequencing (RNA-seq) data in conjunction with Artificial Intelligence offers both an essential need and a remarkable opportunity for developing therapies that target splicing errors. By harnessing machine learning techniques, we can identify new splicing errors and promptly create therapeutic compounds to rectify these issues. Our specialized AI platform, SpliceCore, is dedicated to the discovery of RNA-based therapeutics. This advanced technology excels in analyzing RNA sequencing data with exceptional speed and accuracy. It effectively identifies, assesses, and confirms potential drug targets, surpassing conventional methods in efficiency. A key feature of SpliceCore is our proprietary database, which houses over 5 million potential RNA splicing errors, making it the largest resource of its type worldwide and vital for evaluating any RNA sequencing dataset submitted for analysis. The incorporation of scalable cloud computing enables us to manage extensive RNA sequencing data efficiently and economically, thereby accelerating the development of new therapies. This groundbreaking strategy is set to transform the field of RNA therapeutics, paving the way for unprecedented advancements in treatment options. As we move forward, the potential for discovery in this domain continues to expand, promising a future filled with innovative solutions.

What is Hillo?

We are excited to present a flexible API that integrates effortlessly with your diabetes management platform, providing customized therapeutic education along with deeper insights into fluctuations in blood glucose levels. This innovative solution allows for real-time risk assessments, which promotes a higher degree of personalization and better regulation of the system while skillfully navigating the complexities of rapid glucose changes in daily life. With the rise of telemedicine and the power of retrospective analysis, patients are equipped with comprehensive decision-support tools that enhance their management capabilities. Currently, Hillo is working on the next phases of its AI technology, which includes a therapeutic recommendation system focused on preventing both hypoglycemia and hyperglycemia, with expectations to achieve CE mark class IIB by 2020. Furthermore, a next-generation artificial pancreas is scheduled for release in 2021, set to overcome the critical limitations of current models through ultra-personalization powered by machine learning. This pioneering initiative introduces the first self-learning artificial intelligence, designed to anticipate blood glucose levels, with the goal of obtaining a CE mark as a certified medical device, thus revolutionizing diabetes management for users. Ultimately, the advancements made by Hillo have the potential to greatly improve the quality of life for those living with diabetes, empowering them to manage their condition with newfound confidence and precision.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Envisagenics

Date Founded

2014

Company Location

United States

Company Website

www.envisagenics.com/platform/

Company Facts

Organization Name

Hillo

Company Location

France

Company Website

www.hillo.ai/

Categories and Features

Categories and Features

Popular Alternatives

MapItRight Reviews & Ratings

MapItRight

Custom Software, Inc.

Popular Alternatives

Splice Reviews & Ratings

Splice

Bending Spoons
SPLICE Dialog Suite Reviews & Ratings

SPLICE Dialog Suite

SPLICE Software
Altis Labs Nota Reviews & Ratings

Altis Labs Nota

Altis Labs